There were three companies that had their AIM quotations cancelled in April. All three were taken over or part of a merger deal through an unquoted holding company.
=====
5 April 2022
Clinigen Group
Pharma services provider Clinigen is the third company worth more than £1bn that has left AIM in the past three months and the second of these to be taken over - ASOS (LON:ASC) moved to the Main Market.
Triley Bidco succeeded when it increased the bid for Clinigenfrom 883p a share to 925p a share and that values the pharma services company at £1.2bn. Clinigen shareholders received a...
